Antiparasitic therapy.
Mayo Clin Proc
; 86(6): 561-83, 2011 Jun.
Article
en En
| MEDLINE
| ID: mdl-21628620
ABSTRACT
Parasitic diseases affect more than 2 billion people globally and cause substantial morbidity and mortality, particularly among the world's poorest people. This overview focuses on the treatment of the major protozoan and helminth infections in humans. Recent developments in antiparasitic therapy include the expansion of artemisinin-based therapies for malaria, new drugs for soil-transmitted helminths and intestinal protozoa, expansion of the indications for antiparasitic drug treatment in patients with Chagas disease, and the use of combination therapy for leishmaniasis and human African trypanosomiasis.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Contexto en salud:
3_ND
Problema de salud:
3_chagas_disease
/
3_helminthiasis
/
3_malaria
/
3_neglected_diseases
/
3_trypanosomiasis
/
3_zoonosis
Asunto principal:
Infecciones por Protozoos
/
Helmintiasis
/
Antihelmínticos
/
Antiprotozoarios
Límite:
Humans
Idioma:
En
Revista:
Mayo Clin Proc
Año:
2011
Tipo del documento:
Article
País de afiliación:
Estados Unidos